Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMCR7EF)

Drug Name

CEQ-508 Drug Info

Synonyms

CEQ-501; TkRNAis (oral, familial adenomatous polyposis/colon cancer), Cequent; TkRNAis (oral, familial adenomatous polyposis/colon cancer), Marina

Indication

Disease Entry	ICD 11	Status	REF
Familial adenomatous polyposis	2B90.Y	Phase 1/2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Beta-catenin (CTNNB1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Recombinant human endostatin	DMMPCFX	Solid tumour/cancer	2A00-2F9Z	Approved	[3]
C 82	DMEWXFK	Scleroderma	4A42	Phase 1/2	[4]
Tegavivint	DMPJ3YX	Desmoid tumour	2F7C	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Current Progress of siRNA/shRNA Therapeutics in Clinical Trials. Biotechnol J. 2011 September; 6(9): 1130-1146.
3	Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/beta-catenin signaling pathway. PLoS One. 2014 Sep 18;9(9):e107463.
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5	Tegavivint and the beta-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma. J Natl Cancer Inst. 2019 Nov 1;111(11):1216-1227.